CEPI: USA joins CEPI to support the development of epidemic vaccines
“The U.S. Agency for International Development, USAID, [on Friday] announced US$20 million in financial support of CEPI to advance the development of vaccines against emerging infectious diseases. … The funding — which will be provided by USAID over a five-year period from 2020 and subject to Congressional approval on an annual basis — will be used to support CEPI’s vital vaccine development programs against its current priority diseases: Lassa fever, Middle Eastern Respiratory Syndrome (MERS), Nipah, Chikungunya, Rift Valley Fever, and Ebola…” (10/23).